Physician
Family Medicine
Dr. Jeanne M. Snyder, MD
|
|
Give Review
Jeanne Snyder is an expert in the field of Family Medicine. He graduated from University of Nebraska College of Medicine. Jeanne Snyder is a published doctor. He has 77 publications published. The most current publication "Vascular endothelial growth factor gene expression in human fetal lung in vitro." He accepts all Medicare patients.
Publications
- Differential gene expression in human conducting airway surface epithelia and submucosal glands.
- Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells.
- Surfactant-associated protein A provides critical immunoprotection in neonatal mice.
- 11-Beta hydroxysteroid dehydrogenase type 2 in human adult and fetal lung and its regulation by sex steroids.
- Galectin-1 in secondary alveolar septae of neonatal mouse lung.
- Reduction of glucocorticoid receptor ligand binding by the 11-beta hydroxysteroid dehydrogenase type 2 inhibitor, Thiram.
- Early exposure to a nonhygienic environment alters pulmonary immunity and allergic responses.
- 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.
- Retinoic acid and erythropoietin maintain alveolar development in mice treated with an angiogenesis inhibitor.
- A role for surfactant protein D in innate immunity of the human prostate.
- Alveolarization in retinoic acid receptor-beta-deficient mice.
- Surfactant proteins A and D enhance the phagocytosis of Chlamydia into THP-1 cells.
- Signal transduction events involved in TPA downregulation of SP-A gene expression.
- Altered surfactant protein A gene expression and protein metabolism associated with repeat exposure to inhaled endotoxin.
- Recombinant human SP-A1 and SP-A2 proteins have different carbohydrate-binding characteristics.
- TNF-alpha inhibits SP-A gene expression in lung epithelial cells via p38 MAPK.
- Antisense inhibition of surfactant protein A decreases tubular myelin formation in human fetal lung in vitro.
- Vitamin E alters alveolar type II cell phospholipid synthesis in oxygen and air.
- Somatomedin C/insulin-like growth factor I production by human fetal lung tissue maintained in vitro.
- Differentiation of type II cells of human fetal lung in vitro.
- Maintenance and characterization of human myometrial smooth muscle cells in monolayer culture.
- Structure and function of phosphatidylglycerol-deficient lung surfactant.
- Characterization of rabbit surfactant-associated proteins.
- The effects of hydrocortisone on the biosynthesis of sulfated glycoconjugates by human fetal lung.
- Hormonal regulation of the synthesis of lamellar body phosphatidylglycerol and phosphatidylinositol in fetal lung tissue.
- Role of prolactin, cortisol, and insulin in the regulation of surfactant synthesis by the human fetal lung.
- Multihormonal regulation of surfactant synthesis by human fetal lung in vitro.
- Insulin inhibits the accumulation of the major lung surfactant apoprotein in human fetal lung explants maintained in vitro.
- An ultrastructural, morphometric analysis of rabbit fetal lung type II cell differentiation in vivo.
- Uptake of the 35 kDa major surfactant apoprotein (SP-A) by neonatal rabbit lung tissue.
- Phospholipid composition of lamellar bodies formed by fetal rabbit lung type II cells in organ culture.
- Induction and characterization of the major surfactant apoprotein during rabbit fetal lung development.
- Regulation of the synthesis of the major surfactant apoprotein in fetal rabbit lung tissue.
- Adenosine 3',5'-monophosphate analogs and beta-adrenergic agonists induce the synthesis of the major surfactant apoprotein in human fetal lung in vitro.
- Failure to detect a stimulatory effect of estradiol-17 beta on ovine fetal lung maturation.
- Characterization of alpha 1, beta 1, and gamma 1 laminin subunits during rabbit fetal lung development.
- The concentration of the 35-kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies.
- Glucocorticoid regulation of the major surfactant associated protein (SP-A) and its messenger ribonucleic acid and of morphological development of human fetal lung in ...
- Localization of cystic fibrosis transmembrane conductance regulator mRNA in human fetal lung tissue by in situ hybridization.
- Surfactant protein-A: new insights into an old protein--II.
- Surfactant protein-A: new insights into an old protein--Part I.
- Surfactant protein A in rabbit sinus and middle ear mucosa.
- Regulation of the beta 2 subunit chain of laminin in developing rabbit fetal lung tissue.
- Developmental regulation of surfactant-associated proteins in rabbit fetal lung in vivo.
- A new tool to investigate differences between human SP-A1 and SP-A2.
- Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin.
- Glucocorticoid effects on rabbit fetal lung maturation in vivo: an ultrastructural morphometric study.
- Insulin regulation of messenger ribonucleic acid for the surfactant-associated proteins in human fetal lung in vitro.
- Early-life co-administration of cockroach allergen and endotoxin augments pulmonary and systemic responses.
- The combined effects of insulin and cortisol on surfactant protein mRNA levels.
- Transient surfactant protein B deficiency in a term infant with severe respiratory failure.
- Oxygen modulates the differentiation of human fetal lung in vitro and its responsiveness to cAMP.
- Retinoic acid differentially regulates expression of surfactant-associated proteins in human fetal lung.
- Prostaglandins regulate surfactant protein A (SP-A) gene expression in human fetal lung in vitro.
- In situ hybridization of SP-A mRNA in adult human conducting airways.
- Surfactant protein A (SP-A): the alveolus and beyond.
- Regulation of surfactant protein gene expression by retinoic acid metabolites.
- Localization of epidermal growth factor receptor in alveolar epithelium during human fetal lung development in vitro.
- Glucocorticoid regulation of surfactant-associated proteins in rabbit fetal lung in vivo.
- Mechanism of all trans-retinoic acid and glucocorticoid regulation of surfactant protein mRNA.
- O2 regulates surfactant protein A mRNA transcription and stability in human fetal lung in vitro.
- Insulin inhibits surfactant protein A and B gene expression in the H441 cell line.
- Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro.
- Vascular endothelial growth factor gene expression in human fetal lung in vitro.
- Localization of surfactant-associated protein C (SP-C) mRNA in fetal rabbit lung tissue by in situ hybridization.
- Localization of surfactant-associated proteins SP-A and SP-B mRNA in rabbit fetal lung tissue by in situ hybridization.
- Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells.
- VEGF induces airway epithelial cell proliferation in human fetal lung in vitro.
- SP-A2 gene expression in human fetal lung airways.
- Mice bearing deletions of retinoic acid receptors demonstrate reduced lung elastin and alveolar numbers.
- Antisense inhibition of epidermal growth factor receptor decreases expression of human surfactant protein A.
- Insulin utilizes the PI 3-kinase pathway to inhibit SP-A gene expression in lung epithelial cells.
- Surfactant protein D is present in the human female reproductive tract and inhibits Chlamydia trachomatis infection.
- Glucocorticoid metabolism in the human fetal lung: implications for lung development and the pulmonary surfactant system.
- Regulation of surfactant protein D in the mouse female reproductive tract in vivo.
- Regulation of surfactant protein D in the rodent prostate.
Schools
University of Nebraska College of Medicine
Med College Of Virginia Hospital
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna
- Assurant Health
- Blue Cross Blue Shield
- Commercial Insurance Company
- First Choice Health PPO
- Golden Rule
- Group Health Cooperative
- HealthSmart
- Humana
- Medicaid
- Medicare MCR
- Meritain Health
- MultiPlan
- TriWest Champus
- United Healthcare
- Wells Fargo Insurance
- Worker's Compensation WC
Education
-
Virginia Commonwealth University Health System -
University of Nebraska College of Medicine
Drug Facts
| NPI NUMBER | 1871547869 | |
| NPPES Provider LastName | SNYDER | |
| NPPES Provider FirstName | JEANNE | |
| NPPES Provider ZIPCode | 999016013 | |
| NPPES Provider State | AK | |
| Specialty Description | Family Practice | |
| Total Claim Count | 848.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 164.0 | |
| Percent Opioid Claims | 19.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871547869 |
| Last Name Of The Provider | SNYDER |
| First Name Of The Provider | JEANNE |
| View All |
Similar Doctors
|
|
Dr. Andrew B. Sanders, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew D. Pankow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel S. Conrad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vicki A. Malurkar, MD |
|
|
Dr. Diane L. Liljegren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Maureen M. Northway, FNP-C |
|
|
Dr. Michael B. Rountree, MD
This Doctor is OpenDoctor Recommended.
|